


























<!DOCTYPE html>
<html lang="en">
<head>
	<meta charset="utf-8" />
	<title>NIH Annual Report MH002927</title>

	<!-- <link href='https://fonts.googleapis.com/css?family=Open+Sans:400italic,400,300,600' rel='stylesheet' type='text/css'> -->


<link rel="icon" type="image/x-icon" href="../reportviews/styles/favicons/sci_search.ico" />	<link rel="stylesheet" type="text/css" media="screen" href="../reportviews/styles/searchview.css" />
	<link rel="stylesheet" type="text/css" media="print" href="../reportviews/styles/printreports.css" />

	


<!-- ajax header -->
<script type="text/javascript" src="../scripts/prototype.js"></script>

<script type="text/javascript" src="../scripts/scriptaculous.js"></script>
<script type="text/javascript" src="../scripts/showhide.js"></script>



<script language="javascript">

function runthis (targetDiv,dataSource,setForm) {	

    var handlerFunc = function(t) {
    $(targetDiv).innerHTML = t.responseText;
    }

Ajax.Responders.register({
  onCreate: function() {
  $(targetDiv+"loading").style.display = "block";
 
  },
  onComplete: function() {
   $(targetDiv+"loading").style.display = "none";
  }
})

var allNodes= Form.serialize(setForm);

var myAjax = new Ajax.Request(dataSource, {method:'post',parameters:allNodes,onComplete:handlerFunc});
}


</script>

<!-- ajax header ends -->
</head>
<body><br/><br />


<div style="font-weight: bold; text-align: center;">NIH Annual Intramural Research Report
</div>



<div id="container">
	<div id="content">
	<div class="contentlabel">MH002927-08</div>
	<div class="datacontainer">

<div class="rowdiv">
<div class="headings">
Report Title</div>
</div><div class="rowdiv">
<div class="data">Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders


</div>
</div>





<div class="rowdiv">
<div class="headings">2017 Fiscal Year</div></div>

<div class="rowdiv">
<div class="data"> October 01, 2016 -  September 30, 2017</div></div>


<style>

a  {
    text-decoration: none;
}
</style>

<!-- set up arrays -->






 <!-- ends test for any LIs -->


<div class="rowdiv">
<div class="headings">
Principal Investigator  </div></div>

<div class="rowdiv">
<div class="data">
<div class="topdiv">

<div style="float: left; width: 50%;"> <!-- faculty test -->

Carlos Alberto Zarate; MD

</div>

 <a href="https://irp.nih.gov/pi/carlos-zarate" target="_blank"><span class="irpbutton">
IRP Faculty Profile</a></span>
                        <div class="clearfix"></div> <!-- faculty test -->
</div><br />

</div>

</div>


 <!-- ends test for any pis -->


 <!-- test for any PIs or LIs -->








<div class="rowdiv">
<div class="headings">Research Organization</div>
 </div>
 <div class="rowdiv">
<div class="data">


Section on Neurobiology and Treatment of Mood Disorders, NIMH

</div>
</div>




















<div id="morelabstaff">


<!-- display description li -->





<div class="rowdiv">
<div class="headings">
Lab Staff and Collaborators within the <i>Section on Neurobiology and Treatment of Mood Disorders</i></div>


<div class="morelist">
<form id="morelabstaffu">6 of a total of 27 Lab Staff members are shown. </div>



<div class="rowdiv">
<div class="data">

 <!-- step through any ordered staff -->






Rezvan  Ameli<br />




Elizabeth Day Ballard<br />




Charles Nicholas Barker; BS<br />




Charles Ralph Bender<br />




Nancy E Brutsche<br />




Rafael Augusto Teixeira de Sousa<br />

 <!-- step through any unordered staff -->
 <!-- test for 6 or more ordered labstaff -->







<a href="#" onclick="runthis('morelabstaff','searchview.taf?_function=showmore&ios=L&ipid=101270&onameset=Section on Neurobiology and Treatment of Mood Disorders&isajaxlink=Y&_UserReference=E70E4A52E2422F995B38D5EB','morelabstaffu');  return false;">


<span class="morelist">Show all 27</span></a></form></div>



</div>
</div>
</div>

 <!-- test for display off all staff versus max of six -->
 <!-- test for any labstaff -->




	



<!-- display collaborators from the same IC -->










<div class="rowdiv">
<div class="headings">
Collaborators from other NIMH organizations</div>



<div class="rowdiv">
<div class="data">











Richard  Coppola; SB, DSc  (Magnetoencephalography Core)<br />



Masahiro  Fujita  (Section on PET Neuroimaging Sciences)<br />



Robert  Innis; MD  (Molecular Imaging Branch)<br />



Ellen  Leibenluft; MD  (Section on Mood Dysregulation and Neuroscience)<br />



Kathleen R Merikangas; PhD  (Section on Developmental Genetic Epidemiology)<br />








</div>
</div>





	














	
	<!-- display description li -->












<div class="rowdiv">
<div class="headings">
Extramural Collaborator
 </div>
 
</div>

<div class="rowdiv">
<div class="data">











Todd  Gould; MD
<i>(University of Maryland)</i>
<br />










</div>
</div>




 <!-- if showmore or just first 6 -->

 <!-- if any ex -->
	



<!-- display description li -->
<div class="rowdiv">
<div class="headings">
Keywords
 </div></div>
 <div class="rowdiv">
<div class="data">
Novel Treatment, Depression, Oxidative stress, Anxious Depression, Brain circuits, Epidemiology, Bcl-2, Cytokines, glycine receptor, Major Depressive Disorder, Biomarker, Neurobiology, suicide

</div>
</div>


<!-- goals -->


<div class="rowdiv">
<div class="headings">
Goals and Objectives
 </div></div>
 <div class="rowdiv">
<div class="data">
These projects aim to better understand the neurobiology of treatment-resistant major depressive disorder, bipolar disorder, and suicide and to identify novel therapeutic targets for depression and suicidal thinking. Moreover, the neurobiological effects of treatments and treatment response are explored under this project. In addition, we perform deep phenotyping with the data from all studies conducted in our Branch which includes genetics, neuropsychological testing, structural and brain imaging, electrophysiological studies and peripheral blood measures to identify markers of diagnosis and treatment response. Further, we study symptom and syndrome dimensions of depression (RDoC, NIMH Research Domain Criteria). Finally, we conduct proof-of-concept studies under this protocol to identify putative targets for developing novel antidepressants.<br /><br />Studies underway include:<br />1. A Pathophysiological Study to Determine if Enhancing Glutamate Transporter Function Produces Antidepressant Effects in Patients with Major Depressive Disorder <br /><br />Design: Male and female patients, ages 18 to 65 years, with a diagnosis of major depressive disorder (MDD) will be recruited. This study will consist of the double-blind crossover administration of either diazoxide (200-400 mg/day given orally) or placebo over the course of 3 weeks in improving overall depressive symptomatology in patients with treatment-resistant MDD. Other aims of the study include: 1) determining whether changes in brain neurochemicals (glutamate) correlate with antidepressant response (decrease in Montgomery-Asberg Depression Rating Scale (MADRS) total scores).<br /><br />Outcome measures: Primary: MADRS total score. <br /><br />2. An investigation of the Neurophysiological Effects of Intravenous Alcohol as Potential Biomarkers of Ketamine's Rapid Antidepressant Effects in Major Depressive Disorder. <br /><br />Design: This study is a single-site, open-label protocol in psychotropic medication-free depressed subjects. This protocol consists of two phases (Phase I and Phase II). The first phase consists of the medication taper and drug-free period. The second phase will have three subphases: Subphase IIA (alcohol clamp infusion #1 with neurophysiological assessments), IIB alcohol clamp infusion #2 during 7 Tesla-Magnetic Resonance Spectroscopy/Imaging (7T-MRS/I) and IIC (subanesthetic/antidepressant dose ketamine infusion during 7T-MRS/I). <br /><br />Outcome Measures: The primary hypothesis/outcome measure will be change in mean MADRS total score from the pre-ketamine infusion baseline-to-7 days post-infusion between the Family History Positive or Negative groups. Other exploratory measures include neurophysiological responses to intravenous alcohol infusion, brain neurochemical alterations during intravenous alcohol infusion, and brain neurochemical alterations during intravenous ketamine infusion.<br /><br />3. An Investigation of the Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder <br /><br />Design: Male and female patients, ages 18 to 65 years, with a diagnosis of MDD, currently in an episode of major depression, will be recruited. This study will consist of the double-blind crossover administration of either AV-101 (glycine antagonist, (1,080 or 1,440 mg/day given orally) or placebo. The study will assess the efficacy of 2 weeks of a glycine antagonist compared with placebo in improving overall depressive symptomatology in patients with treatment-resistant MDD. <br />Outcome measures: Primary: Hamilton Depression Rating Scale (HDRS) total score. <br /><br />4. Neurobiology of Suicide<br />The aim of this study is to evaluate possible biomarkers of suicidal thoughts and behaviors in individuals currently experiencing a suicidal crisis.  In taking a dimensional approach to suicide research, we will be able to study phenomenology across Research Domain Criteria (RDoC) units of analysis, from genes through circuits to self-report and experimental interventions.
</div>
</div>
 <!-- allows for earlier years when this data was not collected -->
 <!-- do not even try to display before 2006 -->

<!-- summary -->
<div class="rowdiv">
<div class="headings">
Summary
 </div></div>
 
 <div class="rowdiv">
<div class="data">
This Report involves work collected under protocols 01-M-0254 (NCT00024635 ); 08-M-0196 (NCT00759395); 08-M-0150 (NCT00697268); 14-M-0085 (NCT02122562); 07-M-0021 (NCT00397111); 14-M-0041 (NCT02049385); and 07-M-0152 (NCT00472576), 09-M-N230; 15-M-0151 (NCT 02484456), 15-M-0188 (NCT02543983).<br /><br />Results this past year:<br />1. cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor antidepressant. Basic studies exploring the importance of the cyclic adenosine monophosphate (cAMP) cascade in major depressive disorder (MDD) have noted that the cAMP cascade is downregulated in MDD and upregulated by antidepressant treatment. We investigated cAMP cascade activity by using 11C-(R)-rolipram to image phosphodiesterase-4 (PDE4) in unmedicated MDD patients and after 8 weeks of treatment with a selective serotonin reuptake inhibitor (SSRI). We found in unmedicated MDD patients widespread, 20% reductions in 11C-(R)-rolipram binding compared with controls. SSRI treatment significantly increased rolipram binding, with significantly greater increases observed in older patients. Consistent with the results of basic studies, PDE4 was decreased in unmedicated MDD patients and increased after SSRI treatment. These results suggest that PDE4 inhibitors, which increase cAMP cascade activity, may have antidepressant effect. <br />2. Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder.<br />Patients with major depressive disorder (MDD) have clinically relevant, significant decreases in bone mineral density (BMD). We sought to determine if predictive markers of bone inflammation-the osteoprotegerin (OPG)-RANK-RANKL system or osteopontin (OPN)-play a role in the bone abnormalities associated with MDD and, if so, whether ketamine treatment corrected the abnormalities. Patients with MDD had significant decreases in baseline OPG/RANKL ratio and in plasma OPN levels. Ketamine significantly increased both the OPG/RANKL ratio and plasma OPN levels, and significantly decreased RANKL levels. We conclude that the OPG-RANK-RANKL system and the OPN system play important roles in the serious bone abnormalities associated with MDD. These data suggest that, in addition to its antidepressant effects, ketamine also has a salutary effect on a major medical complication of depressive illness<br />3. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Despite decades of research, the pathophysiology of bipolar disorder (BD) is still not well understood. Structural brain differences have been associated with BD, but results from neuroimaging studies have been inconsistent. To address this, we performed the largest study to date of cortical gray matter thickness and surface area measures from brain magnetic resonance imaging scans of 6503 individuals including 1837 unrelated adults with BD and 2582 unrelated healthy controls for group differences while also examining the effects of commonly prescribed medications, age of illness onset, history of psychosis, mood state, age and sex differences on cortical regions. In BD, cortical gray matter was thinner in frontal, temporal and parietal regions of both brain hemispheres. BD had the strongest effects on left pars opercularis and left rostral middle frontal cortex. Our analysis revealed previously undetected associations and provides an extensive analysis of potential confounding variables in neuroimaging studies of BD.<br />4. Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study. Mitochondrial dysfunction and energy metabolism impairment are key components in the pathophysiology of bipolar disorder (BD) and may involve a shift from aerobic to anaerobic metabolism. Measurement of brain lactate in vivo using proton magnetic resonance spectroscopy (H-MRS) represents an important tool to evaluate mitochondrial and metabolic dysfunction during mood episodes, as well as to monitor treatment response. Subjects with BD depression showed a significantly higher cingulate cortex (CC) lactate in comparison to control subjects. Furthermore, a significant decrease in CC lactate was observed after 6 weeks of lithium treatment compared with baseline. CC Lactate levels was associated with family history of mood disorders and plasma lithium levels. These findings indicate a shift to anaerobic metabolism and a role for lactate as a state marker during mood episodes. <br />5. Active suicidal ideation during clinical antidepressant trials. Suicidal patients are often excluded from clinical trials of psychiatric medications and from investigations using neurobiological techniques. To evaluate the presence, impact, and stability of active suicidal ideation (SI) across a range of antidepressant trials, we reviewed clinical trials conducted in patients with either major depressive disorder (MDD) or bipolar disorder (BD). Across clinical trials, participants (23%) reported active SI at some point during study participation. The results suggest that research can be conducted in depressed patients with active SI if such research coincides with careful observation. Active SI and pessimism may be particularly vulnerable to fluctuation.<br />6. Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.  Anhedonia occurs across psychiatric diagnoses and has been associated with specific neural circuits in response to rapid-acting treatments, such as ketamine. This analysis included treatment-resistant patients with depression from several clinical trials of ketamine. Anhedonia was assessed using a subscale of the Beck Depression Inventory (BDI) and the Snaith-Hamilton Pleasure Scale (SHAPS). One day post-ketamine administration, improvements on the SHAPS accounted for an additional 13% of the variance in suicidal thought reduction, beyond the influence of depressive symptoms. Suicidal thoughts may be related to symptoms of anhedonia independent of other depressive symptoms. <br />7. Acute risk factors for suicide attempts and death: prospective findings from the STEP-BD study. Suicide is unfortunately common in psychiatric practice, but difficult to predict. The present study sought to assess which clinical symptoms increase in the months before suicidal behavior in a sample of psychiatric outpatients with bipolar disorder. Participants were assessed using for the following potential acute risk factors for suicidal behavior: suicidal ideation, loss of interest, anxiety, psychomotor agitation, and high-risk behavior. Each of the five symptoms was elevated overall in individuals who engaged in suicidal behavior. Suicidal ideation, loss of interest and, to a lesser extent, anxiety may represent acute suicide risk factors up to four months before suicidal behavior in outpatients with bipolar disorder. <br />8. Increased activity or energy as a primary criterion for the diagnosis of bipolar mania in DSM-5. DSM-5 describes &quot;a distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently increased activity or energy&quot; as a primary criterion for mania. Using data from the Systematic Treatment Enhancement Program for Bipolar Disorder study, the authors analyzed point prevalence data obtained at the initial visit to assess the diagnostic validity of this new DSM-5 criterion. When the new DSM-5 criterion of increased activity or energy was added as a coprimary symptom, the prevalence of mania and hypomania was reduced. The findings confirm that including increased activity or energy as part of DSM-5 criterion A decreases the prevalence of manic and hypomanic episodes but does not affect longitudinal clinical outcomes.
</div>
</div>
<div id="publications">










	

	
	

	
		
	




<!-- display pubs -->
<form></form>
<form id="publicationsu">
<div class="rowdiv">
<div class="headings">



Publications Generated during the 2017 Reporting Period<br />	

<span class="showlinknospace"><span style="font-weight: normal;font-size:0.8em;">

		



<a href="#" onclick="runthis('publications','searchview.taf?_function=bibs&ipid=101270&allpubs=Y&isajaxlink=Y&_UserReference=E70E4A52E2422F995B38D5EB','publicationsu');  return false;">


See Project Bibliography</a></span></span>
		
	

<div id="publicationsloading" style="display: none;" class="loadingstyle">Loading Bibliography <img src="../NIDBstyles/images/ajaxgifs/blue_bar.gif" alt="Processing ..." width="43" height="11" hspace="5" vspace="0" border="0" align="bottom"></div>
</div></div>

<div class="rowdiv">

<div class="data">












<p style="font-size: 0.8em; font-style: italic;">
Ordered by publication type and then author name.
</p>













<hr />Journal articles<hr />
<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">1.</div>
<div style="margin: -1.6em 0px 5px 2em;">Bolaños-Guzmán CA, Zarate CA (2016). Underrepresented Minorities in Science: ACNP Strives to Increase Minority Representation and Inclusion. Neuropsychopharmacology  41, 2421-3.   https://doi.org/10.1038/npp.2016.71

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/27510298?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987859/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 27510298
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 4987859 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">2.</div>
<div style="margin: -1.6em 0px 5px 2em;">de Sousa RT, Loch AA, Carvalho AF, Brunoni AR, Haddad MR, Henter ID, Zarate CA, Machado-Vieira R (2017) Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders. Neuropsychopharmacology 42:787-800

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/27510426?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312057/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 27510426
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5312057 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">3.</div>
<div style="margin: -1.6em 0px 5px 2em;">Duncan WC, Slonena E, Hejazi NS, Brutsche N, Yu KC, Park L, Ballard ED, Zarate CA (2017). Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties. Biol Psychiatry  82, 361-369.   https://doi.org/10.1016/j.biopsych.2017.03.011

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/28457485?dopt=Abstract" target="_blank">PubMed</a>


           &nbsp;&nbsp;&nbsp;&nbsp;<i>Available in future as a Free Article</i> <!-- looks for PMC translations for in progress or embargoed -->
         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 28457485
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5546993 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">4.</div>
<div style="margin: -1.6em 0px 5px 2em;">Garay RP, Zarate CA, Charpeaud T, Citrome L, Correll CU, Hameg A, Llorca PM (2017) Investigational drugs in recent clinical trials for treatment-resistant depression. Expert Rev Neurother 17:593-609

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/28092469?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418088/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 28092469
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5418088 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">5.</div>
<div style="margin: -1.6em 0px 5px 2em;">Gould TD, Zanos P, Zarate CA (2017) Ketamine Mechanism of Action: Separating the Wheat from the Chaff. Neuropsychopharmacology 42:368-369

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/27909322?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143504/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 27909322
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5143504 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">6.</div>
<div style="margin: -1.6em 0px 5px 2em;">Henter ID, de Sousa RT, Gold PW, Brunoni AR, Zarate CA, Machado-Vieira R (2017) Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression. Expert Rev Clin Pharmacol 10:153-166

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/27781556?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552063/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 27781556
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5552063 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">7.</div>
<div style="margin: -1.6em 0px 5px 2em;">Kishimoto T, Chawla JM, Hagi K, Zarate CA, Kane JM, Bauer M, Correll CU (2016) Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories. Psychol Med 46:1459-72

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/26867988?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116384/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 26867988
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5116384 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">8.</div>
<div style="margin: -1.6em 0px 5px 2em;">Lally N, An L, Banerjee D, Niciu MJ, Luckenbaugh DA, Richards EM, Roiser JP, Shen J, Zarate CA, Nugent AC (2016) Reliability of 7T (1) H-MRS measured human prefrontal cortex glutamate, glutamine, and glutathione signals using an adapted echo time optimized PRESS sequence: A between- and within-sessions investigation. J Magn Reson Imaging 43:88-98

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/26059603?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671833/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 26059603
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 4671833 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">9.</div>
<div style="margin: -1.6em 0px 5px 2em;">Lepow L, Luckenbaugh DA, Park L, Henter ID, Zarate CA (2017) Case series: Antidepressant effects of low-affinity and low-trapping NMDA receptor antagonists did not predict response to ketamine in seven subjects. J Psychiatr Res 86:55-57

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/27914292?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272869/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 27914292
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5272869 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">10.</div>
<div style="margin: -1.6em 0px 5px 2em;">Machado-Vieira R, Gold PW, Luckenbaugh DA, Ballard ED, Richards EM, Henter ID, De Sousa RT, Niciu MJ, Yuan P, Zarate CA (2017) The role of adipokines in the rapid antidepressant effects of ketamine. Mol Psychiatry 22:127-133

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/27046644?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112162/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 27046644
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5112162 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">11.</div>
<div style="margin: -1.6em 0px 5px 2em;">Pennybaker SJ, Luckenbaugh DA, Park LT, Marquardt CA, Zarate CA (2017) Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion. Biol Psychiatry 82:e35-e36

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/28262250?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859935/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 28262250
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5859935 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">12.</div>
<div style="margin: -1.6em 0px 5px 2em;">Pennybaker SJ, Niciu MJ, Luckenbaugh DA, Zarate CA (2017) Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion. J Affect Disord 208:560-566

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/27839782?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154889/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 27839782
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5154889 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">13.</div>
<div style="margin: -1.6em 0px 5px 2em;">Stoddard JJ, Gotts S, Brotman MA, Lever SN, Hsu DE, Zarate CA, Ernst MK, Pine D, Leibenluft E (2016) Aberrant intrinsic functional connectivity within and between corticostriatal and temporal-parietal networks in adults and youth with bipolar disorder. Psychological Medicine, in press.

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">14.</div>
<div style="margin: -1.6em 0px 5px 2em;">Vande Voort JL, Ballard ED, Luckenbaugh DA, Bernert RA, Richards EM, Niciu MJ, Park LT, Machado-Vieira R, Duncan WC, Zarate CA (2017). Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder. J Clin Psychiatry  78, 1068-1074.   https://doi.org/10.4088/JCP.15m10440

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/27929610?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641476/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 27929610
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5641476 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">15.</div>
<div style="margin: -1.6em 0px 5px 2em;">Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, Alkondon M, Yuan P, Pribut HJ, Singh NS, Dossou KSS, Fang Y, Huang XP, Mayo CL, Albuquerque EX, Thompson SM, Thomas CJ, Zarate CA, Gould TD (2017) Zanos et al. reply. Nature 546:E4-E5

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/28640272?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638119/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 28640272
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5638119 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">16.</div>
<div style="margin: -1.6em 0px 5px 2em;">Zanos P, Moaddel R, Morris PJ, Wainer IW, Albuquerque EX, Thompson SM, Thomas CJ, Zarate CA, Gould TD (2017) Reply to: Antidepressant Actions of Ketamine Versus Hydroxynorketamine. Biol Psychiatry 81:e69-e71

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/27817846?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359040/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 27817846
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5359040 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">17.</div>
<div style="margin: -1.6em 0px 5px 2em;">Zarate CA, Machado-Vieira R (2016). GSK-3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput. Bipolar Disord  18, 702-705.   https://doi.org/10.1111/bdi.12452

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/27900801?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222739/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 27900801
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5222739 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">18.</div>
<div style="margin: -1.6em 0px 5px 2em;">Zarate CA, Machado-Vieira R (2017) Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders. Mol Psychiatry 22:324-327

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/28070122?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641407/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 28070122
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5641407 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->


 <!-- ends unordered rows -->
 <!-- test for any unordered pubs -->

 <!-- ends test for any pubs -->

</div>

</div>
</form> <!-- ends form id publicationsu -->
 <!-- show nothing if a non-bib type of project --></div></div>
<div class="showlink">
<hr /><div style="text-align: center; font-weight: bold;"><a href="../search/index.taf">Return to Intramural Search page?</a></div>
</div>
</body></html>